Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Forensic Science, Medicine and Pathology
Erschienen in: Forensic Science, Medicine and Pathology 1/2010

01.03.2010 | Review

The influence of putrefaction and sample storage on post-mortem toxicology results

verfasst von: Danielle M. Butzbach

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

There are numerous biochemical and biological processes that occur after death that may have a significant influence on post-mortem drug concentrations. These processes may render the quantification of particular drugs unreliable, or even result in drugs being undetectable in some instances, despite the use of several methods. Problems may occur with changes in the drug concentration via bacterial degradation, residual tissue enzymatic activity, or via post-mortem redistribution from tissues of a higher to a lower concentration. Many analytical techniques can suffer from interferences due to co-extracted putrefactive compounds that mask or alter the way a drug is detected, depending on the analytical technique utilised. The following paper reviews problems associated with post-mortem drug concentration changes, and the significance of microbial influences during the post-mortem interval and sample storage.
Literatur
1.
Madea B. Is there recent progess in the estimation of the postmortem interval by means of thanatochemistry? Forensic Sci Int. 2005;151:139–49.CrossRefPubMed
2.
Vass AA, Barshick S-A, Sega G, Caton J, Skeen JT, JC Love, et al. Decomposition chemistry of human remains: a new methodology for determining the postmortem interval. J Forensic Sci. 2002;47(3):542–53.PubMed
3.
Evans WED. The chemistry of death. Springfield: Charles C Thomas; 1963.
4.
Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol. 2005;43:235–41.
5.
Robertson MD, Drummer OH. Postmortem drug metabolism by bacteria. J Forensic Sci. 1995;40(3):382–6.PubMed
6.
Pounder DJ, Jones GR. Post-mortem drug redistribution—a toxicological nightmare. Forensic Sci Int. 1990;45:253–63.CrossRefPubMed
7.
Paterson S. Drugs and decomposition. Med Sci Law. 1993;33(2):103–9.PubMed
8.
Haglund WD, Sorg MH. Forensic taphonomy: the postmortem fate of human remains. Boca Raton: CRC Press LLC; 1997.
9.
Spitz WU. Spitz and Fisher’s medicolegal investigation of death. 3rd ed. Springfield: Charles C Thomas; 1993.
10.
Bugg T. An introduction to enzyme and coenzyme chemistry. Oxford: Blackwell Science Ltd; 1997.
11.
Yamazaki M, Wakasugi C. Postmortem changes in drug-metabolizing enzymes of rat liver microsome. Forensic Sci Int. 1994;67:155–68.CrossRefPubMed
12.
Micozzi MS. Postmortem change in human and animal remains: a systematic approach. Springfield: Charles C Thomas; 1991.
13.
Morris JA, Harrison LM, Partridge SM. Practical and theoretical aspects of postmortem bacteriology. Curr Diagn Pathol. 2007;13:65–74.CrossRef
14.
Knight B, Saukko P. Knight’s forensic pathology. 3rd ed. London: Arnold Publishers; 2004.
15.
Morris JA, Harrison LM, Partridge SM. Postmortem bacteriology: a re-evaluation. J Clin Pathol. 2006;59:1–9.CrossRefPubMed
16.
Tsokos M, Puschel K. Postmortem bacteriology in forensic pathology: diagnostic value and interpretation. Legal Med. 2001;3:15–22.CrossRefPubMed
17.
Dix J, Calaluce R, Ernst MF. Guide to forensic pathology. Boca Raton: CRC Press; 1998.
18.
Skopp G. Preanalytical aspects in postmortem toxicology. Forensic Sci Int. 2004;142:75–100.CrossRefPubMed
19.
Dick GL, Stone HM. Alcohol loss arising from microbial contamination of drivers’ blood specimens. Forensic Sci Int. 1987;34:17–27.CrossRefPubMed
20.
Batziris HP, McIntyre IM, Drummer OH. The effect of sulfur-metabolising bacteria on sulfur-containing psychotropic drugs. Int Biodeterior Biodegradation. 1999;44:111–6.CrossRef
21.
Rose GW, Hockett RN. The microbiologic evaluation and enumeration of postmortem specimens from human remains. Health Lab Sci. 1971;8(2):75–8.PubMed
22.
Robertson MD, Drummer OH. Stability of nitrobenzodiazepines in postmortem blood. J Forensic Sci. 1998;43(1):5–8.PubMed
23.
Robertson MD, Drummer OH. Postmortem distribution and redistribution of nitrobenzodiazepines in man. J Forensic Sci. 1998;43(1):9–13.PubMed
24.
Robertson MD (1996) The effect of the post-mortem interval on the concentrations of nitrobenzodiazepines. Doctor of Philosophy Thesis, Monash University.
25.
Anderson WH, Prouty RW. Postmortem redistribution of drugs. In: Baselt RC, editor. Advances in analytical toxicology VII. Chigaco: Year Book Medical Publishers; 1989. p. 70–102.
26.
Rodda KE, Drummer OH. The redistribution of selected psychiatric drugs in post-mortem cases. Forensic Sci Int. 2006;164:235–9.CrossRefPubMed
27.
28.
Bertol E, Trignano C, Di Milia MG, Di Padua M, Mari F. Cocaine-related deaths: an enigma still under investigation. Forensic Sci Int. 2008;176(2–3):121–3.CrossRefPubMed
29.
Logan BK, Smirnow D, Gullberg RG. Lack of predictable site-dependent differences and time-dependent changes in postmortem concentrations of cocaine, benzoylecgonine, and cocaethylene in humans. J Anal Toxicol. 1997;21:23–31.PubMed
30.
Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci. 1990;35(2):243–70.PubMed
31.
Yonemitsu K, Pounder DJ. Postmortem changes in blood tranylcypromine concentration: competing redistribution and degradation effects. Forensic Sci Int. 1993;59:177–84.CrossRefPubMed
32.
Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004;142(2–3):101–13.CrossRefPubMed
33.
Curry AS, Sunshine I. The liver:blood ratio in cases of barbiturate poisoning. Toxicol Appl Pharmacol. 1960;2:602–6.CrossRef
34.
Miyaishi S, Moriya F. Immunoassays, forensic applications. In: Payne-James J, editor. Encyclopedia of forensic and legal medicine. 1st ed. Oxford: Elsevier Academic Press; 2005. p. 73–9.
35.
Lokan RJ (1977) The forensic significance of putrefactive bases. Masters Thesis, University of Strathclyde.
36.
Goeringer KE, Raymon L, Christian GD, Logan BK. Postmortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. J Forensic Sci. 2000;45(3):633–48.PubMed
37.
Saar E, Gerostamoulos D, Drummer OH. Comparison of extraction efficiencies and LC-MS-MS matrix effects using LLE and SPE methods for 19 antipsychotics in human blood. Anal Bioanal Chem. 2009;393(2):727–34.CrossRefPubMed
38.
Moriya F, Hashimoto Y. Distribution of free and conjugated morphine in body fluids and tissues in a fatal heroin overdose: is conjugated morphine stable in postmortem specimens? J Forensic Sci. 1997;42(4):736–40.PubMed
39.
Sawyer WR, Forney RB. Postmortem disposition of morphine in rats. Forensic Sci Int. 1988;38(3–4):259–73.CrossRefPubMed
40.
Spiehler V, Brown R. Unconjugated morphine in blood by radioimmunoassay and gas chromatography/mass spectrometry. J Forensic Sci. 1987;32(4):906–16.PubMed
41.
Mather LE. Opioids: a pharmacologist’s delight! Clin Exp Pharmacol Physiol. 1995;22:833–6.CrossRefPubMed
42.
Rop PP, Grimaldi F, Burle J, De Saint Leger MN, Viala A. Determination of 6-monoacetylmorphine and morphine in plasma, whole blood and urine using high-performance liquid chromatography with electrochemical detection. J Chromatogr B. 1994;661:245–53.CrossRef
43.
Skopp G, Potsch L, Klingmann A, Mattern R. Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples. J Anal Toxicol. 2001;25:2–7.PubMed
44.
Stevens HM. The stability of some drugs and poisons in putrefying human liver tissues. J Forensic Sci Soc. 1984;24:577–89.CrossRefPubMed
45.
Jimenez C, de la Torre R, Ventura M, Segura J, Ventura R. Stability studies of amphetamine and ephedrine derivatives in urine. J Chromatogr B. 2006;843:84–93.CrossRef
46.
Nagata T, Kimura K, Hara K, Kudo K. Methamphetamine and amphetamine concentrations in postmortem rabbit tissues. Forensic Sci Int. 1990;48:39–47.CrossRefPubMed
47.
Moriya F, Hashimoto Y. Postmortem stability of cocaine and cocaethylene in blood and tissues of humans and rabbits. J Forensic Sci. 1996;41(4):612–6.PubMed
48.
Johansen SS, Bhatia HM. Quantitative analysis of cocaine and its metabolites in whole blood and urine by high-performance liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B. 2007;852:338–44.CrossRef
49.
Bouis P, Taccard G, Boelsterli UA. Determination of cocaine and norcocaine in plasma and cell cultures using high-performance liquid chromatography. J Chromatogr. 1990;526:447–59.CrossRefPubMed
50.
Skopp G, Klingman A, Potsch L, Mattern R. In vitro stability of cocaine in whole blood and plasma including ecgonine as a target analyte. Ther Drug Monit. 2001;23:174–81.CrossRefPubMed
51.
Suzuki O, Watanabe K. Drugs and poisons in humans: a handbook of practical analysis. Basel: Birkhauser; 2005.
52.
Levine BS, Blanke RV, Valentour JC. Postmortem stability of benzodiazepines in blood and tissues. J Forensic Sci. 1983;28(1):102–15.PubMed
53.
Entwistle N, Owen P, Patterson DA, Jones LV. The occurrence of chlordiazepoxide degradation products in sudden deaths associated with chlordiazepoxide overdosage. J Forensic Sci Soc. 1986;26:45–54.CrossRefPubMed
54.
Al-Hadidi KA, Oliver JS. Stability of temazepam in blood. J Forensic Sci Soc. 1995;35(2):105–8.
55.
Skopp G, Potsch L, Konig I, Mattern R. A preliminary study on the stability of benzodiazepines in blood and plasma stored at 4C. Int J Legal Med. 1998;111:1–5.CrossRefPubMed
56.
Mahjoub AE. Stability of benzodiazepines in whole blood samples stored at varying temperatures. J Pharm Biomed Anal. 2000;23(6):1057–63.CrossRefPubMed
57.
Pounder DJ, Hartley AK, Watmough PJ. Postmortem redistribution and degradation of dothiepin. Am J Forensic Med Pathol. 1994;15(3):231–5.PubMedCrossRef
58.
Caddy B, Stead AH. Three cases of poisoning involving the drug phenelzine. J Forensic Sci Soc. 1978;18:207–8.CrossRefPubMed
59.
Kwon J-W, Armbrust KL. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ Toxicol Chem. 2006;25(10):2561–8.CrossRefPubMed
60.
Sykutera M, Pufal E, Sliwka K. The influence of temperature and time of storage on the stability of fluoxetine and biological material. Z Zagadnien Nauk Sadowych. 2002;50:5–16.
61.
Binsumait IA, Hadidi KA, Abu-Al Raghib S. Stability of fluoxetine in stored plasma, aqueous and methanolic solutions determined by HPLC with UV detection. Die Pharm. 2001;56(4):311–3.
62.
Asafu-Adjaye EB, Faustino PJ, Tawakkul MA, Anderson LW, Yu LX, Kwon H, et al. Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine. J Pharm Biomed Anal. 2007;43:1854–9.CrossRefPubMed
63.
Coutselinis A, Dimopoulos G, Dritsas C. Fatal intoxication with chlorpromazine with special regard to the influence of putrefaction on its toxicological analysis. Forensic Sci. 1974;4(2):191–4.CrossRefPubMed
64.
Catlow JT, Barton RD, Clemens M, Gillespie TA, Goodwin M, Swanson SP. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr B. 1995;668:85–90.CrossRef
65.
Kostakis C, Kenneally M, Felgate P, Walker GS. Difficulties encountered in the analysis of olanzapine from spiked psot-mortem blood samples. Melbourne: TIAFT; 2003.
66.
van der Zwaal EM, Luijendijk MCM, Adan RAH, la Fleur SE. Olanzapine-induced weight gain: Chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution. Eur J Pharmacol. 2008;585:130–6.CrossRefPubMed
67.
Takayasu T, Ohshima T, Tanaka N, Maeda H, Kondo T, Nishigami J, et al. Postmortem degradation of administered ethanol-d6 and production of endogenous ethanol: experimental studies using rats and rabbits. Forensic Sci Int. 1995;76:129–40.CrossRefPubMed
68.
Hoiseth G, Karinen R, Chrisophersen AS, Olsen L, Normann PT, Morland J. A study of ethyl glucuronide in post-mortem blood as a marker of ante-mortem ingestion of alcohol. Forensic Sci Int. 2007;165:41–5.CrossRefPubMed
69.
Canfield D, Brink J, Johnson R, Lewis R, Dubowski K. Clarification of ethanol-positive case using urine serotonin metabolite ratio. J Anal Toxicol. 2007;31:592–5.PubMed
70.
Hoiseth G, Karinen R, Johnson L, Normann PT, Christopherson AS, Morland J. Disappearance of ethyl glucuronide during heavy putrefaction. Forensic Sci Int. 2008;176(2–3):147–51.CrossRefPubMed
71.
Helander A, Olssen I, Dahl H. Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption. Clin Chem. 2007;53(10):1855–7.CrossRefPubMed
72.
Halter CC, Laengin A, Al-Ahmad A, Wurst FM, Weinmann W, Keummerer K. Assessment of the stability of the ethanol metabolite ethyl sulfate in standardized degradation tests. Forensic Sci Int. 2009;186:52–5.CrossRefPubMed
73.
Elliot S, Burgess V. Investigative implications of the instability and metabolism of mebeverine. J Anal Toxicol. 2006;30:91–7.
74.
Koves EM, Lawrence K, Mayer JM. Stability of diltiazem in whole blood: forensic implications. J Forensic Sci. 1998;43(3):587–97.PubMed
75.
Couper FJ, Drummer OH. Postmortem stability and interpretation of b2-agonist concentrations. J Forensic Sci. 1999;44(3):523–6.PubMed
76.
Ramagiri S, Kosanam H, Sai Prakash PK. Stability study of propoxur (baygon) in whole blood and urine stored at varying temperature conditions. J Anal Toxicol. 2006;30:313–6.PubMed
77.
Holmgren P, Druid H, Holmgren A, Ahlner J. Stability of drugs in stored postmortem femoral blood and vitreous humor. J Forensic Sci. 2004;49(4):6.CrossRef
78.
Moody DE, Monti KM, Spanbauer AC. Long-term stability of abused drugs and antiabuse chemotherapeutical agents stored at −20C. J Anal Toxicol. 1999;23:535–40.PubMed
79.
Eenoo PV, Lootens L, Spaerkeer A, Van Thuyne W, Deventer K, Delbeke FT. Results of stability studies with doping agents in urine. J Anal Toxicol. 2007;31:543–8.PubMed
80.
Lokan RJ, James RA, Dymock RB. Apparent post-mortem production of high levels of cyanide in blood. J Forensic Sci Soc. 1987;27:253–9.CrossRefPubMed
81.
Elliot SP, Lowe P, Symonds A. The possible influence of micro-organisms and putrefaction in the production of GHB in post-mortem biological fluid. Forensic Sci Int. 2004;139(2–3):183–90.CrossRef
82.
Baselt RC. Disposition of toxic drugs and chemicals in man. 6th ed. Foster City: Biomedical Publications; 2002.
83.
Berankova K, Mutnanska K, Balikova M. Gamma-hydroxybutyric acid stability and formation in blood and urine. Forensic Sci Int. 2006;161(2–3):158–62.CrossRefPubMed
84.
Hardman JK, Stadtman TC. Metabolism of g-amino acids: fermentation of g-aminobutyric acid by Clostridium aminobutyricum. J Bacteriol. 1960;79:544–8.PubMed
85.
Levine BS, Blanke RV, Valentour JC. Postmortem stability of barbiturates in blood and tissues. J Forensic Sci. 1984;29(1):131–8.PubMed
86.
Boumba VA, Ziavrou KS, Vougiouklakis T. Biochemical pathways generating post-mortem volatile compounds co-detected during forensic ethanol analyses. Forensic Sci Int. 2008;174:133–51.CrossRefPubMed
87.
Zaitsu K, Miki A, Katagi M, Tsuchihashi H. Long-term stability of various drugs and metabolites in urine, and preventative measures against their decomposition with special attention to filtration sterilization. Forensic Sci Int. 2008;174(2–3):189–96.CrossRefPubMed
Metadaten
Titel
The influence of putrefaction and sample storage on post-mortem toxicology results
verfasst von
Danielle M. Butzbach
Publikationsdatum
01.03.2010
Verlag
Humana Press Inc
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 1/2010
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-009-9130-8

Weitere Artikel der Ausgabe 1/2010

Forensic Science, Medicine and Pathology 1/2010 Zur Ausgabe

What's New Beyond Forensics

What’s new beyond forensics?

Case Report

Congenital mesenteric abnormality causing death in an infant with a concurrent diaphragmatic hernia

Original Article

Prediction of nasal morphology from the skull

Book Review

Stuart L. Houser, M.D.: The Operated Heart at Autopsy

DIFFERENTIAL DIAGNOSIS

Infiltrating carcinoma of the breast mimicking electrocution

Review

Basil RuDusky: Forensic cardiovascular medicine

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Zielgerichtete Therapie Leitthema

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …